BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3600671)

  • 1. [Significance of serum fructosamine in the metabolic control of children and adolescents with type I diabetes mellitus].
    Krause M; Pfüller H; Herbst D; Kruse K
    Monatsschr Kinderheilkd; 1987 Apr; 135(4):200-3. PubMed ID: 3600671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum fructosamine and glycated haemoglobin measurements in diabetic control.
    Hindle EJ; Rostron GM; Clark SA; Gatt JA
    Arch Dis Child; 1986 Feb; 61(2):113-7. PubMed ID: 3954436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HbA1 and glycosylated serum proteins in type I diabetic patients].
    Gottschling HD; Pusch H; Michaelis D
    Z Med Lab Diagn; 1989; 30(1):70-2. PubMed ID: 2718584
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal changes in serum fructosamine do not parallel those in glycated haemoglobin in young adults with insulin-dependent diabetes.
    Fisken RA; Chan AW; Hanlon A; MacFarlane IA
    Clin Chim Acta; 1990 Oct; 191(1-2):79-86. PubMed ID: 2073735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fructosamine correlates with gingival index in children with insulin-dependent diabetes mellitus (IDDM).
    Firatli E; Unal T; Saka N; Onan U; Sivas A; Oz H
    J Clin Periodontol; 1994 Sep; 21(8):565-8. PubMed ID: 7989622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
    MacRury SM; Kilpatrick ES; Paterson KR; Dominiczak MH
    Clin Chim Acta; 1991 May; 199(1):51-8. PubMed ID: 1934502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U; Sedlmayer A; Müller MM; Dorda W; Schernthaner G
    Klin Wochenschr; 1989 Apr; 67(7):379-85. PubMed ID: 2747138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum fructosamine in healthy and diabetic children and adolescents].
    Schlebusch H; Liappis N; Sorger M; Paffenholz I; Koch HC
    Klin Padiatr; 1991; 203(3):173-7. PubMed ID: 1857053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of changes in concentration of glycosylated hemoglobin and fructosamine during the first three weeks of treatment of children with newly diagnosed insulin-dependent diabetes].
    Adamczyk A; Ciechanowska M; Dziatkowiak H; Szafran Z
    Endokrynol Pol; 1993; 44(4):507-15. PubMed ID: 8055819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fructosamine assay in children with insulin-dependent diabetes mellitus.
    Shimojo N; Hirai M; Naka K; Yoshikawa C; Okuda K; Aono S; Isshiki G; Fujii S
    Clin Chim Acta; 1988 Aug; 176(1):101-6. PubMed ID: 3168288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructosamine: an alternative assessment of past glycaemic control in developing countries.
    Islam N; Akhter J; Kayani N; Khan MA
    J Pak Med Assoc; 1993 Nov; 43(11):238-40. PubMed ID: 8114262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fructosamine and glycated haemoglobin in children with type 1 (insulin-dependent) diabetes mellitus.
    Mullis P; Völkle H; Sigrist V; Zuppinger K
    Diabetologia; 1988 Jun; 31(6):351-4. PubMed ID: 3417057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
    Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
    Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of fructosamine determination in diabetic patients and its relation to metabolic control.
    Daubresse JC; Laurent E; Ligny C; Bailly A; Lemy C; Duchateau A; Meunier JC
    Diabete Metab; 1987 Jun; 13(3):217-21. PubMed ID: 3609423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2,070 simultaneous determinations of blood glucose, glucosylated hemoglobin and fructosamine as index of metabolic control in 519 diabetic patients].
    Gómez Reyes D; Gea T; Rojas Hidalgo E
    Rev Clin Esp; 1989 Nov; 185(7):354-8. PubMed ID: 2623250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the assay of serum fructosamine in the surveillance of diabetes in children and adolescents].
    Berrah H; Khiari M; Ourabia A; Boukerrou F; Berhoune A; Keddari M
    Pediatrie; 1989; 44(4):323-5. PubMed ID: 2798002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of serum fructosamine activity in type I diabetic children.
    Cefalu WT; Mejia E; Puente GR; Fleishhacker D; Macaulay K
    Am J Med Sci; 1989 Apr; 297(4):244-6. PubMed ID: 2705464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluctuations in albumin on serum fructosamine assay.
    McCance DR; Coulter D; Smye M; Kennedy L
    Diabet Med; 1987; 4(5):434-6. PubMed ID: 2959433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.